Acorn Capital Advisors, LLC Y M Abs Therapeutics, Inc. Transaction History
Acorn Capital Advisors, LLC
- $144 Billion
- Q1 2025
A detailed history of Acorn Capital Advisors, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Acorn Capital Advisors, LLC holds 3,235,387 shares of YMAB stock, worth $13.7 Million. This represents 9.97% of its overall portfolio holdings.
Number of Shares
3,235,387
Previous 2,861,825
13.05%
Holding current value
$13.7 Million
Previous $22.4 Billion
36.04%
% of portfolio
9.97%
Previous 11.76%
Shares
4 transactions
Others Institutions Holding YMAB
# of Institutions
103Shares Held
27.1MCall Options Held
38.4KPut Options Held
2.1K-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$17.9 Million0.96% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$12.4 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$9.26 Million0.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$8.21 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$7.73 Million0.05% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $184M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...